Goodrx Holdings, INC Form 4 insider transactions

GoodRx Holdings, Inc. reported that its Chief Accounting Officer, Romin Nabiey, was granted 108,189 restricted stock units.

GoodRx Holdings, Inc. CEO and President Wendy Lynn Barnes was granted 1,331,557 restricted stock units, vesting quarterly over three years.

GoodRx Chief Accounting Officer Romin Nabiey reported the future vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

GoodRx Holdings, Inc. Director Scott Wagner acquired 31,394 shares of Class A Common Stock following the vesting of deferred stock units on January 21, 2026.

GoodRx Director and Officer Wendy Lynn Barnes reported the exercise of restricted stock units and subsequent tax-related sales of Class A Common Stock on January 15, 2026.

GoodRx Holdings, Inc. Director Douglas Joseph Hirsch reported the acquisition of 10,950 deferred stock units under a Rule 10b5-1 plan.

GoodRx Holdings, Inc. Director Ronald E Bruehlman acquired 18,251 deferred stock units, increasing his direct beneficial ownership to 129,276 shares.

GoodRx Holdings, Inc. Director Kelly J. Kennedy converted 23,149 restricted stock units into Class A common stock, increasing her direct beneficial ownership.

GoodRx's Chief Accounting Officer, Romin Nabiey, reported planned future transactions involving the exercise of restricted stock units and subsequent sale of shares for tax withholding.

GoodRx Chief Accounting Officer Romin Nabiey reported the acquisition of Class A common stock and restricted stock units, alongside a disposition of shares for tax purposes.

GoodRx Chief Accounting Officer Romin Nabiey reported the acquisition of shares from restricted stock units and subsequent sale for tax purposes.

GoodRx Holdings Director Ronald E Bruehlman acquired 21,691 shares of Class A Common Stock through the conversion of deferred stock units.

GoodRx Holdings, Inc. Director Trevor Bezdek was granted restricted stock units, aligning his interests with long-term shareholder value.

GoodRx Holdings Director Scott Wagner acquired 3,065 deferred stock units, increasing his direct beneficial ownership.

GoodRx Holdings, Inc. Director Douglas Joseph Hirsch acquired 20,521 Class A Common Stock shares through the vesting of restricted stock units.

Spectrum Equity entities converted Class B shares to Class A and subsequently sold or distributed a significant portion of their holdings in GoodRx Holdings, Inc.

GoodRx Holdings, Inc.'s Chief Accounting Officer, Romin Nabiey, reported routine transactions involving the vesting of restricted stock units and subsequent share sales for tax purposes.

Spectrum Equity entities, a 10% owner of GoodRx Holdings, Inc., converted Class B shares to Class A, distributed a significant block of shares, and sold a portion of Class A shares.

GoodRx Director Agnes Rey-Giraud transferred 75,219 Class A common shares to a family trust, maintaining indirect beneficial ownership.

GoodRx Chief Accounting Officer Romin Nabiey reported the vesting of restricted stock units and a related tax-driven share disposition.

GoodRx Chief Accounting Officer Romin Nabiey reported the acquisition and disposition of Class A Common Stock related to RSU vesting.

GoodRx Holdings, Inc. Director Ian T Clark exercised 17,248 restricted stock units, acquiring Class A Common Stock, and now directly owns 100,150 shares.

Spectrum Equity, a 10% owner of GoodRx Holdings, Inc., converted a significant block of Class B shares to Class A, subsequently distributing a large portion, while affiliated funds sold smaller amounts of Class A shares.

GoodRx Holdings, Inc.'s Chief Accounting Officer, Romin Nabiey, reported the acquisition of Class A Common Stock through the vesting and conversion of Restricted Stock Units (RSUs), alongside the disposition of shares to cover tax obligations.

Spectrum Equity, a significant shareholder in GoodRx Holdings, Inc., has reported the conversion of millions of Class B shares to Class A, followed by a large pro rata distribution to its partners and the sale of a portion of these shares.

GoodRx Holdings, Inc. Director Ian T. Clark has reported the acquisition of 57,050 Class A Common Stock shares through a restricted stock unit grant, increasing his direct beneficial ownership to 82,902 shares.

GoodRx Holdings, Inc. Director Kelly J. Kennedy was granted 57,050 restricted stock units, aligning her interests with shareholders.

GoodRx Holdings, Inc. Director Agnes Rey-Giraud was granted 57,050 deferred stock units, increasing her total beneficial ownership to 160,667 Class A common shares.

GoodRx Holdings, Inc. Director Douglas Joseph Hirsch was granted 57,050 deferred stock units, increasing his direct beneficial ownership to 211,388 shares, with additional indirect holdings through grantor retained annuity trusts.

GoodRx Holdings, Inc. Director Ronald E. Bruehlman was granted 57,050 deferred stock units, convertible into Class A common stock, as part of his compensation, vesting on the earlier of June 3, 2026, or the 2026 Annual Meeting.